Bottom line
What does BIB hold?
BIB held 267 positions as of May 31, 2026. Its largest holding is N/a at 7.35% of the fund, and the top 10 positions add up to 43%. By asset type it is 16% equity derivatives, 63% stocks, 3% repurchase agreements.
Updated Jul 28, 2026
BIB top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | N/a Total Return Swap |
Equity derivatives | 7.35% | $5.4M |
| 2 | ProShares GENIUS Money Market ETF | Other | 6.80% | $5.0M |
| 3 | Gilead Sciences, Inc. | Stocks | 4.66% | $3.4M |
| 4 | Vertex Pharmaceuticals, Inc. | Stocks | 4.65% | $3.4M |
| 5 | Amgen, Inc. | Stocks | 4.48% | $3.3M |
| 6 | N/a Total Return Swap |
Equity derivatives | 3.94% | $2.9M |
| 7 | N/a Total Return Swap |
Equity derivatives | 3.26% | $2.4M |
| 8 | Regeneron Pharmaceuticals, Inc. | Stocks | 3.21% | $2.4M |
| 9 | N/a Total Return Swap |
Equity derivatives | 2.62% | $1.9M |
| 10 | Alnylam Pharmaceuticals, Inc. | Stocks | 2.01% | $1.5M |
| 11 | Revolution Medicines, Inc. | Stocks | 1.57% | $1.2M |
| 12 | Biogen, Inc. | Stocks | 1.44% | $1.1M |
| 13 | Repurchase Agreement | Repurchase agreements | 1.28% | $944.6K |
| 14 | Illumina, Inc. | Stocks | 1.25% | $921.2K |
| 15 | United Therapeutics Corp. | Stocks | 1.22% | $902.0K |
| 16 | Royalty Pharma plc Royalty Pharma plc, Class A |
Stocks | 1.20% | $883.1K |
| 17 | Argenx SE | Stocks | 1.19% | $877.8K |
| 18 | N/a Total Return Swap |
Equity derivatives | 1.18% | $871.2K |
| 19 | Insmed, Inc. | Stocks | 1.16% | $851.9K |
| 20 | Roivant Sciences Ltd. | Stocks | 1.08% | $793.5K |
| 21 | Incyte Corp. | Stocks | 0.97% | $711.9K |
| 22 | Viatris, Inc. | Stocks | 0.94% | $692.1K |
| 23 | Moderna, Inc. | Stocks | 0.94% | $689.0K |
| 24 | Guardant Health, Inc. | Stocks | 0.85% | $629.0K |
| 25 | Invesco Govt And Agcy Lex INVESCO GOVERNMENT & AGENCY PORTFOLIO OPEN-END FUND USD |
Cash & short-term funds | 0.81% | $598.0K |
Source: SEC Form N-PORT, period ended May 31, 2026, filed Jul 28, 2026